Home › Asset managers › Compare 2025-2026 › JPMorgan vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,192 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
JPMorgan 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 30,213 | 24,386 | 1,617 | 4,210 | 93.8% | 88.5% |
| Board proposals | 24,151 | 19,144 | 1,472 | 3,535 | 92.9% | 87.8% |
| E&S shareholder proposals | 137 | 0 | 0 | 137 | n/a | 40.7% |
| Other items | 5,925 | 5,242 | 145 | 538 | 97.3% | 92.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,535 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | JPMorgan | Brighthouse |
|---|---|---|---|---|---|---|
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| 10X GENOMICS, INC. | June 4, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Director for terms expiring April 2029: Timothy K. Ozark Director Elections |
Board | For | Split 2 FOR, 1 AGAINST |
FOR 1 fund |
| 3M COMPANY | May 12, 2026 | Advisory approval of executive compensation. Say-on-Pay |
Board | For | FOR 33 funds |
Split 4 FOR, 1 AGAINST, 6 ABSTAIN |
| 3M COMPANY | May 12, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm. Audit-related |
Board | For | FOR 30 funds |
Split 4 FOR, 1 AGAINST, 6 ABSTAIN |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
Split 3 AGAINST, 1 ABSTAIN |
| A10 NETWORKS, INC. | April 22, 2026 | To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| AAON, INC. | May 12, 2026 | Proposal to approve, on an advisory basis, a resolution on the compensation of AAON's named executive officers as set forth in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 2 ABSTAIN |
| AAR CORP. | September 16, 2025 | Election of four directors named in the proxy statement: Ellen M. Lord Director Elections |
Board | For | FOR 2 funds |
Split 2 FOR, 1 AGAINST, 1 ABSTAIN |
| AAR CORP. | September 16, 2025 | Election of four directors named in the proxy statement: Jeffrey N. Edwards Director Elections |
Board | For | FOR 2 funds |
Split 2 FOR, 2 AGAINST, 1 ABSTAIN |
| AAR CORP. | September 16, 2025 | Election of four directors named in the proxy statement: John M. Holmes Director Elections |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| AAR CORP. | September 16, 2025 | Election of four directors named in the proxy statement: Marc J. Walfish Director Elections |
Board | For | FOR 2 funds |
Split 2 FOR, 1 AGAINST, 1 ABSTAIN |
| ABBOTT LABORATORIES | April 24, 2026 | Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees Compensation |
Board | For | FOR 11 funds |
Split 9 FOR, 3 AGAINST |
| ABBOTT LABORATORIES | April 24, 2026 | Ratification of Ernst & Young LLP As Auditors Audit-related |
Board | For | FOR 11 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBOTT LABORATORIES | April 24, 2026 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay |
Board | For | FOR 14 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 Audit-related |
Board | For | FOR 37 funds |
Split 10 FOR, 4 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay |
Board | For | FOR 40 funds |
Split 9 FOR, 1 AGAINST, 4 ABSTAIN |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026. Say-on-Pay |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Approval, on a non-binding advisory basis, of the fiscal 2025 compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2026 PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Ratification of the appointment of KPMG LLP as the registered public accounting firm of Acadian Asset Management Inc. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 2 ABSTAIN |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| ACCELERANT HOLDINGS | May 12, 2026 | to consider and vote upon the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 1 FOR, 2 ABSTAIN |
| ACCIONA SA | June 24, 2026 | Reelect Jeronimo Marcos Gerard Rivero as Director Director Elections |
Board | For | FOR 1 fund |
Split 2 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Maria Salgado Madrinan as Director Director Elections |
Board | For | FOR 1 fund |
Split 2 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Teresa Sanjurjo Gonzalez as Director Director Elections |
Board | For | FOR 1 fund |
Split 2 FOR, 1 AGAINST |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 2 funds |
Split 2 FOR, 1 AGAINST |
| ACCOR SA | May 27, 2026 | Approve Compensation of Sébastien Bazin, Chairman and CEO Say-on-Pay |
Board | For | FOR 1 fund |
Split 1 FOR, 2 AGAINST |
| ACCOR SA | May 27, 2026 | Approve Remuneration Policy of Chairman and CEO Say-on-Pay |
Board | For | AGAINST 1 fund |
Split 1 FOR, 5 AGAINST |
| ACCOR SA | May 27, 2026 | Reelect Bruno Pavlovsky as Director Director Elections |
Board | For | FOR 1 fund |
Split 5 FOR, 1 AGAINST |
| ACI WORLDWIDE, INC. | June 2, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026; Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 3 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | AGAINST 1 fund |
Split 2 AGAINST, 2 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 2 ABSTAIN |
| ACM RESEARCH, INC. | June 10, 2026 | Ratification of appointment of Ernst & Young Hua Ming LLP as independent auditor for year 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUSHNET HOLDINGS CORP. | June 8, 2026 | To approve, in a non-binding advisory vote, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ACUSHNET HOLDINGS CORP. | June 8, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ACV AUCTIONS INC. | May 27, 2026 | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026; Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 4 FOR, 2 ABSTAIN |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 4 FOR, 2 ABSTAIN |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | AGAINST 4 funds |
Split 4 FOR, 1 AGAINST |
| ADIDAS AG | May 7, 2026 | APPROVE MANAGEMENT BOARD REMUNERATION POLICY Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST |
| ADIDAS AG | May 7, 2026 | REELECT NASSEF SAWIRIS TO THE SUPERVISORY BOARD Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST |
| ADMA BIOLOGICS, INC. | June 2, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 4 FOR, 2 ABSTAIN |
| ADMA BIOLOGICS, INC. | June 2, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 2 ABSTAIN |
| ADT INC. | May 27, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| ADT INC. | May 27, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP to be the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 2 ABSTAIN |
| ADTRAN HOLDINGS, INC. | May 13, 2026 | Non-binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ADTRAN HOLDINGS, INC. | May 13, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ADVANCE AUTO PARTS, INC. | May 20, 2026 | Approve, by advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| ADVANCE AUTO PARTS, INC. | May 20, 2026 | Ratify the appointment of Deloitte & Touche LLP (Deloitte) as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of an amendment to the Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares; Capital Structure |
Board | For | FOR 4 funds |
Split 8 FOR, 3 AGAINST |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 4 funds |
Split 3 FOR, 5 AGAINST, 3 ABSTAIN |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Ratification of the appointment of Ernst & Young LLP as Advanced Energy's independent registered public accounting firm for 2026; Audit-related |
Board | For | FOR 4 funds |
Split 8 FOR, 3 ABSTAIN |
| ADVANCED MICRO DEVICES, INC. | May 13, 2026 | Approve an amendment and restatement of the Advanced Micro Devices, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 26 funds |
Split 9 FOR, 6 ABSTAIN |
| ADVANCED MICRO DEVICES, INC. | May 13, 2026 | Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the current fiscal year. Audit-related |
Board | For | FOR 26 funds |
Split 8 FOR, 1 AGAINST, 6 ABSTAIN |
| ADVANSIX INC | June 22, 2026 | An advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| ADVANSIX INC | June 22, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for 2026. Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| AENA SME SA | April 16, 2026 | REELECT MAURICI LUCENA BETRIU AS DIRECTOR Director Elections |
Board | For | FOR 3 funds |
Split 1 FOR, 3 AGAINST |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
Split 5 FOR, 1 ABSTAIN |
| AFFILIATED MANAGERS GROUP, INC. | May 27, 2026 | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 5 FOR, 2 ABSTAIN |
| AFFILIATED MANAGERS GROUP, INC. | May 27, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year. Audit-related |
Board | For | FOR 3 funds |
Split 5 FOR, 2 ABSTAIN |
| AFLAC INCORPORATED | May 4, 2026 | to consider and act upon the ratification of the appointment of KPMG LLP as independent registered public accounting firm of the Company for the year ending December 31, 2026 Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 1 AGAINST, 1 ABSTAIN |
| AGCO CORPORATION | April 23, 2026 | Non-binding advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 5 FOR, 2 ABSTAIN |
| AGCO CORPORATION | April 23, 2026 | Ratification of KPMG LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 5 funds |
Split 5 FOR, 2 ABSTAIN |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| AGREE REALTY CORPORATION | May 14, 2026 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
Split 3 FOR, 1 AGAINST, 2 ABSTAIN |
| AGREE REALTY CORPORATION | May 14, 2026 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 2 ABSTAIN |
| AIRBNB INC | June 5, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 6 FOR, 2 AGAINST, 3 ABSTAIN |
| AIRBNB INC | June 5, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 8 FOR, 3 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | AGAINST 5 funds |
Split 1 FOR, 4 AGAINST, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve the Company's 2026 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 5 funds |
Split 5 FOR, 2 AGAINST |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 5 FOR, 2 ABSTAIN |
| AKER BP ASA | April 21, 2026 | Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights Capital Structure |
Board | For | AGAINST 5 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares Capital Structure |
Board | For | AGAINST 5 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Reelect Charles Ashley Heppenstall as Director Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Reelect Doris Reiter as Director Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Reelect Oyvind Eriksen (Chair) as Director Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST |
| AKZO NOBEL NV | April 23, 2026 | Approve Supplement to Remuneration Policy in Respect of M.J. de Vries Compensation |
Board | For | AGAINST 1 fund |
Split 2 FOR, 3 AGAINST |
| ALAMO GROUP INC. | May 1, 2026 | Proposal FOR approval of the advisory vote on the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
Split 5 FOR, 1 ABSTAIN |
| ALAMO GROUP INC. | May 1, 2026 | Proposal FOR ratification of the appointment of KPMG LLP as the Company's Independent Auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 5 FOR, 1 ABSTAIN |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ALASKA AIR GROUP, INC. | May 12, 2026 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accountants for fiscal year 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| ALBEMARLE CORPORATION | May 5, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 3 FOR, 3 ABSTAIN |
| ALBEMARLE CORPORATION | May 5, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 3 FOR, 3 ABSTAIN |
Page 1 of 36 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.